Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Adverum Biotechnologies

Market Cap: US$58.7m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

Assertio Holdings

Market Cap: US$58.4m

A pharmaceutical company, provides various products to patients in the United States.

Immix Biopharma

Market Cap: US$57.9m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Repare Therapeutics

Market Cap: US$57.8m

A clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.

Applied Therapeutics

Market Cap: US$56.6m

A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.

Metagenomi

Market Cap: US$56.4m

A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.

ECO Animal Health Group

Market Cap: UK£42.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Skye Bioscience

Market Cap: US$56.1m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

FluoGuide

Market Cap: SEK 543.4m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Serina Therapeutics

Market Cap: US$55.9m

A biotechnology company, develops drugs to treat neurological diseases and pain.

Akoya Biosciences

Market Cap: US$54.8m

A life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

Ikena Oncology

Market Cap: US$54.5m

An oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.

PDS Biotechnology

Market Cap: US$54.5m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Gain Therapeutics

Market Cap: US$53.9m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Medicus Pharma

Market Cap: US$53.8m

A biotech/life sciences company, focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.

Precision BioSciences

Market Cap: US$53.8m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

Covalon Technologies

Market Cap: CA$72.1m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Vivoryon Therapeutics

Market Cap: €46.0m

Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.

Karyopharm Therapeutics

Market Cap: US$51.5m

A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Artiva Biotherapeutics

Market Cap: US$50.7m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Adicet Bio

Market Cap: US$50.4m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

Fortress Biotech

Market Cap: US$49.9m

A biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States.

Outlook Therapeutics

Market Cap: US$49.9m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Solasia Pharma K.K

Market Cap: JP¥7.2b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

OKYO Pharma

Market Cap: US$49.2m

A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

PepGen

Market Cap: US$49.1m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

ABIONYX Pharma

Market Cap: €42.2m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

Cinclus Pharma Holding

Market Cap: SEK 456.1m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

Armata Pharmaceuticals

Market Cap: US$46.7m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Medical Developments International

Market Cap: AU$72.1m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Century Therapeutics

Market Cap: US$46.3m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Actinium Pharmaceuticals

Market Cap: US$46.2m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Sernova Biotherapeutics

Market Cap: CA$64.1m

Operates as a clinical-stage biotechnology company in Canada.

PMV Pharmaceuticals

Market Cap: US$45.8m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Shattuck Labs

Market Cap: US$45.4m

A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.

Mural Oncology

Market Cap: US$45.3m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.